1. Home
  2. TTNP vs IBG Comparison

TTNP vs IBG Comparison

Compare TTNP & IBG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TTNP
  • IBG
  • Stock Information
  • Founded
  • TTNP 1991
  • IBG 2018
  • Country
  • TTNP United States
  • IBG Australia
  • Employees
  • TTNP N/A
  • IBG N/A
  • Industry
  • TTNP Biotechnology: Biological Products (No Diagnostic Substances)
  • IBG Beverages (Production/Distribution)
  • Sector
  • TTNP Health Care
  • IBG Consumer Staples
  • Exchange
  • TTNP Nasdaq
  • IBG Nasdaq
  • Market Cap
  • TTNP 5.4M
  • IBG 5.4M
  • IPO Year
  • TTNP 1996
  • IBG 2024
  • Fundamental
  • Price
  • TTNP $4.33
  • IBG $0.36
  • Analyst Decision
  • TTNP
  • IBG Strong Buy
  • Analyst Count
  • TTNP 0
  • IBG 1
  • Target Price
  • TTNP N/A
  • IBG N/A
  • AVG Volume (30 Days)
  • TTNP 89.3K
  • IBG 603.6K
  • Earning Date
  • TTNP 08-14-2025
  • IBG 11-15-2025
  • Dividend Yield
  • TTNP N/A
  • IBG N/A
  • EPS Growth
  • TTNP N/A
  • IBG N/A
  • EPS
  • TTNP N/A
  • IBG N/A
  • Revenue
  • TTNP N/A
  • IBG $2,931,243.00
  • Revenue This Year
  • TTNP N/A
  • IBG N/A
  • Revenue Next Year
  • TTNP N/A
  • IBG N/A
  • P/E Ratio
  • TTNP N/A
  • IBG N/A
  • Revenue Growth
  • TTNP N/A
  • IBG N/A
  • 52 Week Low
  • TTNP $3.03
  • IBG $0.30
  • 52 Week High
  • TTNP $6.43
  • IBG $3.35
  • Technical
  • Relative Strength Index (RSI)
  • TTNP 48.74
  • IBG 33.07
  • Support Level
  • TTNP $3.90
  • IBG $0.30
  • Resistance Level
  • TTNP $4.55
  • IBG $0.48
  • Average True Range (ATR)
  • TTNP 0.37
  • IBG 0.07
  • MACD
  • TTNP 0.00
  • IBG -0.01
  • Stochastic Oscillator
  • TTNP 45.99
  • IBG 18.05

About TTNP Titan Pharmaceuticals Inc.

Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.

About IBG Innovation Beverage Group Limited Ordinary Shares

Innovation Beverage Group Ltd is a developer, manufacturer, marketer, exporter, and retailer of a growing beverage portfolio of 70 formulations across 14 alcoholic and non-alcoholic brands. The company's focus is on premium and super premium brands. The Group has two reportable geographic segments: Australia and the United States.

Share on Social Networks: